BIOND BIOLOGICS LTD.

Organization

Misgav, IL

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods and compositions for decreasing soluble immune receptor CD28
- Patent number 12,139,534
- Issue date Nov 12, 2024
- BIOND BIOLOGICS LTD.
- Motti Hakim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against ILT2 and use thereof
- Patent number 12,071,479
- Issue date Aug 27, 2024
- BIOND BIOLOGICS LTD.
- Ilana Mandel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF CANCER WITH ANTI-ILT2 ANTIBODIES
- Publication number 20250019441
- Publication date Jan 16, 2025
- BIOND BIOLOGICS LTD.
- Dana Haves Ziv
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTRACELLULAR DELIVERY COMPOSITIONS
- Publication number 20240350648
- Publication date Oct 24, 2024
- BIOND BIOLOGICS LTD.
- Orit SHILOVITZKY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR DECREASING SOLUBLE IMMUNE RECEPTOR CD28
- Publication number 20240309094
- Publication date Sep 19, 2024
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- G01 - MEASURING TESTING
Information Patent Application
CD28 SHEDDING BLOCKING AGENTS
- Publication number 20240279335
- Publication date Aug 22, 2024
- BIOND BIOLOGICS LTD.
- Anna FRIDMAN-DROR
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTRACELLULAR DELIVERY COMPOSITIONS
- Publication number 20240148886
- Publication date May 9, 2024
- BIOND BIOLOGICS LTD.
- Orit SHILOVITZKY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATORY COMPOSTIONS AND USE THEREOF
- Publication number 20240010706
- Publication date Jan 11, 2024
- BIOND BIOLOGICS LTD.
- Ilana MANDEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLUBLE CD28 LEVELS AFTER IMMUNOTHERAPY
- Publication number 20230221325
- Publication date Jul 13, 2023
- BIOND BIOLOGICS LTD.
- Anna FRIDMAN-DROR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SHEDDING BLOCKING AGENTS WITH INCREASED STABILITY
- Publication number 20230144459
- Publication date May 11, 2023
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF MMP INHIBITION
- Publication number 20230041599
- Publication date Feb 9, 2023
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLUBLE CD28 LEVELS DURING IMMUNOTHERAPY
- Publication number 20230035730
- Publication date Feb 2, 2023
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- G01 - MEASURING TESTING
Information Patent Application
SMALL SHEDDING BLOCKING AGENTS
- Publication number 20220169732
- Publication date Jun 2, 2022
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Against ILT2 and Use Thereof
- Publication number 20220153836
- Publication date May 19, 2022
- BIOND BIOLOGICS LTD.
- Ilana MANDEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A METHOD FOR IMMUNOSUPPRESSION
- Publication number 20220153845
- Publication date May 19, 2022
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Against ILT2 and Use Thereof
- Publication number 20220048991
- Publication date Feb 17, 2022
- BIOND BIOLOGICS LTD.
- Ilana MANDEL
- G01 - MEASURING TESTING
Information Patent Application
Antibodies Against ILT2 and Use Thereof
- Publication number 20210277112
- Publication date Sep 9, 2021
- BIOND BIOLOGICS LTD.
- Ilana MANDEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR DECREASING SOLUBLE IMMUNE RECEPTOR CD28
- Publication number 20210047411
- Publication date Feb 18, 2021
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- G01 - MEASURING TESTING

BIOND BIOLOGICS LTD.

Organization

Patents Grantslast 30 patents

Methods and compositions for decreasing soluble immune receptor CD28

Antibodies against ILT2 and use thereof

Patents Applicationslast 30 patents

TREATMENT OF CANCER WITH ANTI-ILT2 ANTIBODIES

INTRACELLULAR DELIVERY COMPOSITIONS

METHODS AND COMPOSITIONS FOR DECREASING SOLUBLE IMMUNE RECEPTOR CD28

CD28 SHEDDING BLOCKING AGENTS

INTRACELLULAR DELIVERY COMPOSITIONS

IMMUNOMODULATORY COMPOSTIONS AND USE THEREOF

SOLUBLE CD28 LEVELS AFTER IMMUNOTHERAPY

SHEDDING BLOCKING AGENTS WITH INCREASED STABILITY

USE OF MMP INHIBITION

SOLUBLE CD28 LEVELS DURING IMMUNOTHERAPY

SMALL SHEDDING BLOCKING AGENTS

Antibodies Against ILT2 and Use Thereof

A METHOD FOR IMMUNOSUPPRESSION

Antibodies Against ILT2 and Use Thereof

Antibodies Against ILT2 and Use Thereof

METHODS AND COMPOSITIONS FOR DECREASING SOLUBLE IMMUNE RECEPTOR CD28

Trademarklast 30 trademarks